These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12904152)

  • 1. Short- and long-term safety of glaucoma drugs.
    Schuman JS
    Expert Opin Drug Saf; 2002 Jul; 1(2):181-94. PubMed ID: 12904152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.
    Razeghinejad MR; Sawchyn AK; Katz LJ
    Expert Opin Pharmacother; 2010 Apr; 11(6):959-68. PubMed ID: 20307220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiglaucoma medications: a review of safety and tolerability issues related to their use.
    Schuman JS
    Clin Ther; 2000 Feb; 22(2):167-208. PubMed ID: 10743979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and efficacy of glaucoma medication in the pediatric population.
    Coppens G; Stalmans I; Zeyen T; Casteels I
    J Pediatr Ophthalmol Strabismus; 2009; 46(1):12-8. PubMed ID: 19213271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological therapy for glaucoma: a review.
    Hoyng PF; van Beek LM
    Drugs; 2000 Mar; 59(3):411-34. PubMed ID: 10776828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of fixed-dose combination drugs for the treatment of glaucoma.
    Khouri AS; Realini T; Fechtner RD
    Drugs Aging; 2007; 24(12):1007-16. PubMed ID: 18020533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents.
    Hoyng PF; Rulo A; Greve E; Watson P; Alm A
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S93-8. PubMed ID: 9154283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of glaucoma: focus on pharmacological therapy.
    Marquis RE; Whitson JT
    Drugs Aging; 2005; 22(1):1-21. PubMed ID: 15663346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.
    Boyle JE; Ghosh K; Gieser DK; Adamsons IA
    Ophthalmology; 1999 Dec; 106(12 Suppl):10-6. PubMed ID: 10598692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical management of the childhood glaucomas.
    Talbot AW; Russell-Eggitt I
    Expert Opin Pharmacother; 2000 May; 1(4):697-711. PubMed ID: 11249511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of the efficacy and safety of alpha2-adrenergic agonists, beta-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs.
    Tanna AP; Rademaker AW; Stewart WC; Feldman RM
    Arch Ophthalmol; 2010 Jul; 128(7):825-33. PubMed ID: 20625041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical therapy for glaucoma: what to add after a prostaglandin analogs?
    Tanna AP; Lin AB
    Curr Opin Ophthalmol; 2015 Mar; 26(2):116-20. PubMed ID: 25594765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacology aspects of glaucoma].
    Alm A; Berggren L
    Nord Med; 1992; 107(12):306-8, 318. PubMed ID: 1361228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular hypotensive effect and safety of brinzolamide ophthalmic solution in open angle glaucoma patients.
    Wang TH; Huang JY; Hung PT; Shieh JW; Chen YF
    J Formos Med Assoc; 2004 May; 103(5):369-73. PubMed ID: 15216404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group.
    Boyle JE; Ghosh K; Gieser DK; Adamsons IA
    Ophthalmology; 1998 Oct; 105(10):1945-51. PubMed ID: 9787368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2.
    Schuman JS
    Ophthalmology; 2000 Jun; 107(6):1171-7. PubMed ID: 10857839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments in the drug treatment of glaucoma.
    Hurvitz LM; Kaufman PL; Robin AL; Weinreb RN; Crawford K; Shaw B
    Drugs; 1991 Apr; 41(4):514-32. PubMed ID: 1711957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.
    García Sanchez J
    Eur J Ophthalmol; 2000; 10(3):198-204. PubMed ID: 11071026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.